Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma. - Chen CT; Chuang CH; Hsu CH; Shao YY (Journal of hepatocellular carcinoma, 2025)